Alzheimer’s Disease and treatment
Alzheimer’s disease is a progressive neurodegenerative disorder marked by amyloid and tau protein pathology that leads to gradual decline in memory, function, and behavior; management combines accurate staging, symptomatic cognitive therapies, comprehensive non‑pharmacologic care, and, in eligible early cases, disease‑modifying anti‑amyloid monoclonal antibodies with structured MRI safety monitoring. Evidence‑based symptomatic options include acetylcholinesterase inhibitors and … Read more